Ypsomed starts production in Mecklenburg-Vorpommern
The Swiss diabetes specialist Ypsomed has started production at its new plant in Schwerin. The medtech company develops and manufactures injection and infusion systems for self-medication. In total, Ypsomed will invest more than 80 million euros in the Schwerin facility, where injection and infusion systems as well as infusion sets for insulin pumps will be produced. Around 150 new jobs are to be created in the medium term.
Over the last years, companies from Switzerland have created around 2,600 jobs in the federal state of Mecklenburg-Vorpommern, especially in the fields of medical technology, food, and metal processing.